![](/img/cover-not-exists.png)
Phase 1 Dose Escalation Study of MEDI-565, a Bispecific T-cell Engager That Targets Human Carcinoembryonic Antigen, in Patients With Advanced Gastrointestinal Adenocarcinomas
Pishvaian, Michael, Morse, Michael A., McDevitt, Jennifer, Norton, Jonathan D., Ren, Song, Robbie, Gabriel J., Ryan, Patricia C., Soukharev, Serguei, Bao, Haifeng, Denlinger, Crystal S.Language:
english
Journal:
Clinical Colorectal Cancer
DOI:
10.1016/j.clcc.2016.07.009
Date:
August, 2016
File:
PDF, 857 KB
english, 2016